1.421 articles found

Hsa_Circ_0105596/FTO inhibits progression of Parkinson's disease by sponging miR-187-3p and regulating eEF2.

Feng J, Zhao J, Kuang Y, Zhou Y, Ye Z, He Y, Chen D, Zhang L, Zhang T, Zhu Q, Cheng S, Liu T.

Heliyon · 2024-11-02

DOI: 10.1016/j.heliyon.2024.e39830PMID: 39654770

Clinical progression of Parkinson's disease in the early 21st century: Insights from the accelerating medicine partnership (AMP-PD) data.

Lewis MM, Mailman RB, Cheng XV, Du G, Zhang L, Li C, De Jesus S, Tabbal SD, Li R, Huang X.

Parkinsonism Relat Disord · 2024-11-02

DOI: 10.1016/j.parkreldis.2024.107186PMID: 39541725

Unraveling the interplay of β-amyloid pathology and Parkinson's disease progression: Insights from autopsy-confirmed patients

Chen L, Lu H, Mao L, Lin J, Liu P.

Heliyon · 2024-11-01

Comparing machine learning and deep learning models to predict cognition progression in Parkinson's disease.

Bernal EA, Yang S, Herbst K, Venuto CS.

Clin Transl Sci · 2024-11-01

DOI: 10.1111/cts.70066PMID: 39513668

Impact of Dance or Music and Meditation on the Progression of Parkinson Disease With Mild or Moderate Severity: Protocol for a Pilot Randomized Controlled Trial.

Mehrotra B, Rai N, Mr R, Budhakar A, Aggarwal R, Agarbattiwala RV, Thomas M, Patole S, Doshi P.

JMIR Res Protoc · 2024-10-29

DOI: 10.2196/59018PMID: 39471378

Progression trajectories from prodromal to overt synucleinopathies: a longitudinal, multicentric brain [¹⁸F]FDG-PET study.

Orso B, Mattioli P, Yoon EJ, Kim YK, Kim H, Shin JH, Kim R, Famà F, Brugnolo A, Massa F, Chiaravalloti A, Fernandes M, Spanetta M, Placidi F, Pardini M, Bauckneht M, Morbelli S, Lee JY, Liguori C, Arnaldi D.

NPJ Parkinsons Dis · 2024-10-25

DOI: 10.1038/s41531-024-00813-zPMID: 39448609

Medication recommendation for Parkinson's disease based on dynamics of symptom progression.

Oh M, Kim H, Lee HK.

Sci Rep · 2024-10-23

DOI: 10.1038/s41598-024-76941-6PMID: 39443590

Temporal ordering of cognitive impairment in Parkinson's disease patients based on disease progression models.

Platero C, Pineda-Pardo JÁ.

Parkinsonism Relat Disord · 2024-10-21

DOI: 10.1016/j.parkreldis.2024.107184PMID: 39490065

LncRNA MALAT1 Facilitates Parkinson's Disease Progression by Increasing SOCS3 Promoter Methylation.

Liu Y, Feng D, Liu F, Liu Y, Zuo F, Wang Y, Chen L, Guo X, Tian J.

Gerontology · 2024-10-16

DOI: 10.1159/000541719PMID: 39413738

PET Imaging with [<sup>18</sup>F]ROStrace Detects Oxidative Stress and Predicts Parkinson's Disease Progression in Mice.

Zhu Y, Kohli N, Young A, Sheldon M, Coni J, Rajasekaran M, Robinson L, Chroneos R, Riley S, Guarnieri JW, Jose J, Patel N, Wallace DC, Li S, Lee H, Mach RH, McManus MJ.

Antioxidants (Basel) · 2024-10-12

DOI: 10.3390/antiox13101226PMID: 39456479

Lignans of Schisandra chinensis (Turcz.) Baill inhibits Parkinson's disease progression through mediated neuroinflammation-TRPV1 expression in microglia.

Wang SY, Li MM, Wu JT, Sun Y, Pan J, Guan W, Naseem A, Algradi AM, Kuang HX, Jiang YK, Yao HY, He XX, Li H, Yang BY, Liu Y.

Phytomedicine · 2024-10-11

DOI: 10.1016/j.phymed.2024.156146PMID: 39454375

Unraveling the interplay of β-amyloid pathology and Parkinson's disease progression: Insights from autopsy-confirmed patients.

Chen L, Lu H, Mao L, Lin J, Liu P.

Heliyon · 2024-10-10

DOI: 10.1016/j.heliyon.2024.e39194PMID: 39524781